Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysis.

IF 2.3 4区 医学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY International Journal of Biological Markers Pub Date : 2022-03-01 Epub Date: 2022-02-14 DOI:10.1177/17246008221076145
Cunye Yan, Chenyu Sun, Dengwei Lu, Tianming Zhao, Xiuxiu Ding, Irma Zamir, Mi Tang, Cong Shao, Fan Zhang
{"title":"Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysis.","authors":"Cunye Yan,&nbsp;Chenyu Sun,&nbsp;Dengwei Lu,&nbsp;Tianming Zhao,&nbsp;Xiuxiu Ding,&nbsp;Irma Zamir,&nbsp;Mi Tang,&nbsp;Cong Shao,&nbsp;Fan Zhang","doi":"10.1177/17246008221076145","DOIUrl":null,"url":null,"abstract":"<p><p>Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases, which play critical roles in cancer progression and metastasis. In recent years, many researchers have been studying the relationship between MMP9 and breast cancer. However, it still remains indecisive. Therefore, we conducted a meta-analysis to draw more accurate conclusions. A total of 21 relevant documents were retrieved, including 25 case-control studies. We quantitatively analyzed the data obtained. To clarify the relationship between MMP9 polymorphism and breast cancer susceptibility under different conditions, we also made a further subgroup analysis for each locus. In summary, we discovered that MMP9 rs3918242 rendered an increased risk for breast cancer, especially among Iranians and Indians. MMP9 rs3787268 could be a protective factor. MMP9 rs17576 and MMP9 rs2250889 have no association with breast cancer risk.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biological Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17246008221076145","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 10

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases, which play critical roles in cancer progression and metastasis. In recent years, many researchers have been studying the relationship between MMP9 and breast cancer. However, it still remains indecisive. Therefore, we conducted a meta-analysis to draw more accurate conclusions. A total of 21 relevant documents were retrieved, including 25 case-control studies. We quantitatively analyzed the data obtained. To clarify the relationship between MMP9 polymorphism and breast cancer susceptibility under different conditions, we also made a further subgroup analysis for each locus. In summary, we discovered that MMP9 rs3918242 rendered an increased risk for breast cancer, especially among Iranians and Indians. MMP9 rs3787268 could be a protective factor. MMP9 rs17576 and MMP9 rs2250889 have no association with breast cancer risk.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
估计MMP9基因多态性与乳腺癌之间的关系:来自荟萃分析的证据。
基质金属蛋白酶(Matrix metalloproteinases, MMPs)是一类锌依赖性内肽酶,在癌症的进展和转移中起着重要作用。近年来,许多研究人员一直在研究MMP9与乳腺癌的关系。然而,它仍然犹豫不决。因此,我们进行了meta分析,以得出更准确的结论。共检索到21份相关文献,包括25份病例对照研究。我们对获得的数据进行了定量分析。为了明确不同条件下MMP9多态性与乳腺癌易感性的关系,我们还对每个位点进行了进一步的亚群分析。总之,我们发现MMP9 rs3918242增加了患乳腺癌的风险,尤其是在伊朗人和印度人中。MMP9 rs3787268可能是保护因素。MMP9 rs17576和MMP9 rs2250889与乳腺癌风险无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Biological Markers
International Journal of Biological Markers 医学-生物工程与应用微生物
CiteScore
4.10
自引率
0.00%
发文量
43
期刊介绍: IJBM is an international, online only, peer-reviewed Journal, which publishes original research and critical reviews primarily focused on cancer biomarkers. IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment.
期刊最新文献
Circulating exosomal miRNA-451 as an effective diagnostic biomarker and prognostic indicator for multiple myeloma. Inflammatory markers related to survival in breast cancer patients: Peru. Alteration of lncRNA RHPN1-AS1 predicts clinical prognosis and regulates the progression of bladder cancer via modulating miR-485-5p. Serum LINC00339 is a promising biomarker for prognosis prediction of nasopharyngeal carcinoma. Value of the HOTAIR expression assay in predicting therapy target in hepatocellular carcinoma: A meta-analysis and bioinformatics analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1